Dr. Meena T. Malhotra warns patients about 5 critical GLP-1 drug mistakes

3 articles · Updated · Fox News · Apr 26

Dr. Malhotra, a Chicago-based weight-loss specialist, highlights risks of improper GLP-1 use, including self-prescribing online without medical evaluation and insufficient protein intake.
She emphasizes starting with lifestyle changes, gradual dose increases, and ongoing medical monitoring to maximize benefits and minimize side effects such as nausea and loss of lean muscle mass.
GLP-1 drugs like semaglutide and tirzepatide, initially for diabetes, are now widely used for weight loss and show potential cardiovascular and kidney benefits, but misuse can undermine health outcomes.

With 1,000+ adverse events, what are the hidden dangers of unregulated GLP-1s sold online?

Weight returns after stopping GLP-1s. Is an experimental drug the only real solution to prevent the rebound?

For kidney protection, new studies pit GLP-1s against other drugs. Which is the superior choice for patients?

Heart attack risk returns after stopping GLP-1s. Is this a lifetime drug commitment?

These drugs demand high protein intake but suppress appetite. How do patients solve this nutritional paradox?

These drugs can melt away muscle with fat. How can you ensure you’re losing the right kind of weight?